Clinical pharmacokinetics and metabolism of paclitaxel after polychemotherapy with the cytoprotective agent amifostine

Anticancer Research

Volumn 20, Issue 5 C, 2000, Pages 3871-3877

  Czejka, M ^a   Schueller, J ^a   Eder, I ^a   Reznicek, G ^a   Kraule, C ^a   Zeleni, U ^a   Freitag, R ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Amifostine; Drug interaction; Metabolism; Paclitaxel; Pharmacokinetics

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; AMIFOSTINE; PACLITAXEL;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOTRANSFORMATION; BREAST CANCER; CANCER CHEMOTHERAPY; CELL PROTECTION; CONTROLLED STUDY; CYTOSTASIS; HUMAN; PRIORITY JOURNAL;

AGED; AMIFOSTINE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; BIOTRANSFORMATION; BREAST NEOPLASMS; FEMALE; HALF-LIFE; HUMANS; INFUSIONS, INTRAVENOUS; METABOLIC CLEARANCE RATE; MIDDLE AGED; PACLITAXEL; RADIATION-PROTECTIVE AGENTS;

EID: 0034529374     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Paclitaxel: Pharmacology and metabolism
2. Antitumor treatment: Alternative formulations of paclitaxel
3. Chemoprotectants: A review of their clinical pharmacology and therapeutic efficacy
4. Amifostine (WR-2721): A selective systemic protector
5. Bestimmung von amifostin im serum mittels eines einfachen phosphat tests: Anwendung fur drug-monitoring in der chemotherapie
6. Pharmacokinetics of amifostine in cancer patients: Evidence of saturable mechanism
7. Uptake of WR-2721 derivatives by cells in culture: Identification of the transported form of the drug
8. Radioprotection of cells in culture by WR-2721 and derivatives: Form of the drug responsible for protection
9. Chemoprotectants: A review of their clinical pharmacology and thera - Peutic efficacy
10. Amifostine (ethyol): Pharmacokinetic and pharma-codynamic effects in vivo
11. In vitro untersuchungen zur bindung von epirubicin an humane plasmaproteine: Interaktion mit dem zytoprotektivum amifostine
12. Pharma-cokinetic interaction of paclitaxel, docetaxel and their vehicles with doxorubicin
13. Comparative effects of paclitaxel and doce-taxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients
14. Binding of Taxol to human plasma, albumin and alpha-1-acid glycoprotein
15. Pharmacology and Metabolism of paclitaxel
16. Taxol metabolism: Isolation and identification of three major metabolites in rat bile
17. In vitro investigations on the interaction of amifostine, doxorubicin or epirubicin on the cell uptake and metabolism of paclitaxel or docetaxel